Display Settings:

Format

Send to:

Choose Destination
    Nat Genet. 2008 Mar;40(3):281-3. Epub 2008 Feb 10.

    Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.

    Source

    deCODE genetics, 101 Reykjavik, Iceland. julius@decode.is

    Abstract

    We conducted a genome-wide SNP association study on prostate cancer on over 23,000 Icelanders, followed by a replication study including over 15,500 individuals from Europe and the United States. Two newly identified variants were shown to be associated with prostate cancer: rs5945572 on Xp11.22 and rs721048 on 2p15 (odds ratios (OR) = 1.23 and 1.15; P = 3.9 x 10(-13) and 7.7 x 10(-9), respectively). The 2p15 variant shows a significantly stronger association with more aggressive, rather than less aggressive, forms of the disease.

    PMID:
    18264098
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Click here to read

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk